AMP
50
3
PPG
60
3
OKE
67
5
DVN
22
2
QCOM
59
3
HAL
34
7
EQT
48
6
EQIX
59
2
CRM
67
2
GOOG
83
4
K
53
5
GE
64
4
GT
47
4
DOV
50
2
CME
61
2
AXP
67
4
PEP
36
3
AZO
50
2
PCG
66
5
GM
61
4
AMP
50
3
PPG
60
3
OKE
67
5
DVN
22
2
QCOM
59
3
HAL
34
7
EQT
48
6
EQIX
59
2
CRM
67
2
GOOG
83
4
K
53
5
GE
64
4
GT
47
4
DOV
50
2
CME
61
2
AXP
67
4
PEP
36
3
AZO
50
2
PCG
66
5
GM
61
4
Financhill
Back

Nova Lifestyle 10K Form

Sell
36

NVFY
Nova Lifestyle

Last Price:
$0.52
Seasonality Move:
1.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVFY News And Ratings

See the #1 stock for the next 7 days that we like better than NVFY

NVFY Financial Statistics

Sales & Book Value

Annual Sales: $11.1M
Cash Flow: $-437.9K
Price / Cash Flow: 0
Annual Sales: $-0.24
Price / Book: 83.82

Profitability

EPS (TTM): -4.50000
Net Income (TTM): $-9.2M
Gross Margin: $4.2M
Return on Equity: -1289.9%
Return on Assets: -144.13%

Nova Lifestyle Earnings Forecast

Key Nova Lifestyle Financial Ratios

  • The Gross Profit Margin over the past 14 years for NVFY is 37.64%.
  • The Selling, General & Administrative Expenses for NVFY have been equal to 67.41% of Gross Profit Margin.
  • The Research & Development expenses have been 28.12% of Revenue.
  • The Interest Expense is -25.04% of Operating Income.
  • The Net Earning history of NVFY is -69.66% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

Nova Lifestyle Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Household Durables
Sector: Consumer Discretionary
Current Symbol: NVFY
CUSIP: 66979P
Website: novalifestyle.com

Debt

Debt-to-Equity Ratio: -0.58
Current Ratio: 0.71
Quick Ratio: 0.07

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVFY Technical Analysis vs Fundamental Analysis

Sell
36
Nova Lifestyle (NVFY) is a Sell

Is Nova Lifestyle a Buy or a Sell?

  • Nova Lifestyle stock is rated a Sell
    The current Nova Lifestyle [NVFY] share price is $0.53. The Score for NVFY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.